Virica is a cell enhancer company dedicated to improving manufacturing productivity and reducing production costs of cell and gene therapies (CGTs) and vaccines. Virica’s Viral Sensitizers (VSE™) are small-molecule media additives that temporarily dampen host-cell defenses, enhancing viral yields and improving vector quality and transduction efficiency across diverse manufacturing platforms. Beyond supplying VSEs as off-the-shelf reagents, Virica operates as a fast-turnaround service partner: our proprietary High-Throughput Virology (HTV™) platform, Design of Experiments (DoE) process optimization, and analytical testing workflows let developers rapidly pinpoint the best transfection or transduction conditions so programs can move to scale sooner and at lower cost.